| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), SNSE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 1.24M | - | - | |
| Pres | 220.0K | - | - | |
| 10% | 130.6K | $2.61M | - | |
| 10% | 130.1K | $2.75M | - | |
| Other | 80.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Stephenson Brian C | Chief Financial Officer | Buy | 15,641 | $25.65 | $401,268.52 | +89.8% | - | - | |
| Jun 1, 2026 | Peyer James | 10% Owner, See Remarks Below | Sell | 25,000 | $20.02 | $500,542.64 | -16.1% | - | - | |
| Jun 1, 2026 | Cambrian Biopharma Inc | 10% Owner | Sell | 25,000 | $20.02 | $500,542.64 | -16.1% | - | - | |
| Dec 9, 2025 | Peyer James | - | Sale+OE | 6,612 | $8.25 | $54,574.77 | -4.1% | +270.1% | - | |
| Dec 9, 2025 | Cambrian Biopharma Inc | - | Sale+OE | 6,612 | $8.25 | $54,574.77 | -4.1% | +270.1% | - | |
| Dec 5, 2025 | Cambrian Biopharma Inc | - | Sell | 21,295 | $10.93 | $232,689.97 | -11.7% | +213.8% | - | |
| Dec 5, 2025 | Peyer James | - | Sell | 21,295 | $10.93 | $232,689.97 | -11.7% | +213.8% | - | |
| Sep 11, 2023 | Celebi John | President And CEO | Buy | 500 | $0.85 | $425.00 | +0.5% | -17.8% | -31.2% | |
| Jun 1, 2023 | Apeiron Investment Group Ltd.48 | 10% Owner | Sell | 3,441,661 | $1.58 | $5,437,824.38 | -100% | -29.5% | -49.3% | |
| Feb 23, 2023 | Apeiron Investment Group Ltd.48 | 10% Owner | Buy | 2,200 | $1.61 | $3,539.03 | - | -0.6% | -53.4% |